Low blood levels of LRG1 before radical prostatectomy identify patients with high risk of progression to castration-resistant prostate cancer

Low blood levels of LRG1 before radical prostatectomy identify patients with high risk of progression to castration-resistant prostate cancer

<strong>Background<br></strong> After radical prostatectomy (RP), depending on stage, up to 40% of patients with prostate cancer (PCa) will experience biochemical failure (BF). Despite salvage therapy, approximately one-third of these patients will need permanent hormone therapy (p...

Full description

Bibliographic Details
Main Authors: Guldvik, IJ, Braadland, PR, Sivanesan, S, Ramberg, H, Kristensen, G, Tennstedt, P, Røder, A, Schlomm, T, Berge, V, Eri, LM, Lilleby, W, Mills, IG, Taskén, KA
Format: Journal article
Language:English
Published: Elsevier 2022

Similar Items

Similar Items